We have sat in enough boardrooms and leadership meetings to recognise the pattern.
The absence report goes up on screen. The rate is discussed. A manager is asked why their team numbers are higher than average. Occupational health is mentioned. A new policy is referenced. And then the meeting moves on - because nobody in the room has the data to go any deeper than the number itself.
This is not a failure of leadership. It is a failure of information.
The scale is larger than most organisations realise
According to the Office for National Statistics, UK workers lost 148.9 million working days to sickness or injury in 2024¹. That figure - already significant - sits above pre-pandemic levels despite a slight improvement on 2023. The CIPD's employer survey puts the average higher still, at 9.4 days per employee². WTW's absence research describes UK absence as having reached its highest level in a decade³.
Three different measurement approaches. One consistent picture. Absence is not a marginal problem - it is a structural one.
What makes this picture more striking is what sits alongside it. The IPPR Commission on Health and Prosperity, publishing its final report in 2024, found that the cost of worker illness to UK businesses rose by £30 billion between 2018 and 2023⁴. Of that £30 billion increase, £25 billion was driven not by absence - the days people were not at work - but by presenteeism⁴. People who were present, at their desks, on their shifts, but not working at full capacity.
Absence is the visible part of a much larger picture. And most organisations are only looking at the visible part.
What absence data tells you - and what it doesn't
Most absence management systems are genuinely useful at what they were built to do. They record who was absent, for how long, under what category. They flag trigger points. They prompt return-to-work conversations. For the administrative management of absence, they work well.
What they were never designed to do is answer the questions that actually determine what action to take.
Is this a clinical health problem or an organisational one - driven by work design, workload or management conditions? Is this team carrying systemic risk that will surface in the next quarter? And is the investment going into occupational health, EAP and wellbeing programmes changing the underlying conditions - or managing the consequences of conditions that remain unaddressed?
These are not peripheral questions. They are the questions that separate organisations that move their absence rate from those that track it for years without material improvement.
Absence is a symptom. The causes sit upstream.
Here is the thing about absence that gets lost in the reporting cycle: it is almost never the problem itself. It is the signal that something else has been building.
The conditions that generate absence - chronic work pressure, poor work design, management practices that inadvertently increase psychosocial risk, health conditions that have been present for weeks or months before they surface as lost days - are upstream of the absence event. By the time absence appears on a report, those conditions have typically been operating for some time.
This matters for a practical reason: when the cause is organisational rather than clinical, supporting the individual who is absent does not change the conditions their colleagues are also working in. The care is right and necessary. But the underlying pattern continues.
Deloitte's 2024 research puts the annual cost of poor mental health to UK employers at £51 billion⁵ - with presenteeism, not absence, as the largest single contributor. The IPPR found that employees lose the equivalent of 44 days of productive capacity per year through working while unwell⁴. Both figures point to the same conclusion: the dominant cost is not the days people miss. It is the capacity lost while they are there.
The shift that changes the picture
The organisations we have seen move their absence rate meaningfully share one characteristic: they stopped treating absence as the unit of analysis and started treating the conditions generating it as the unit of analysis.
That shift requires a different kind of data. Not who was absent and for how long - but which conditions, at team level, are carrying the highest risk. Whether the drivers are clinical or organisational. Which management practices are most strongly associated with elevated absence in that specific organisation. And whether the interventions already in place are changing the underlying picture or simply managing its consequences.
This is not an argument against absence management. It is an argument for adding intelligence to it. The tracking, the return-to-work process, the occupational health referral - all of that remains valuable and important. What changes is the upstream picture that tells you where to focus, what is driving it, and whether what you are doing is working.
Most organisations are investing in the right programmes. The question is whether they have the data to know if those programmes are working - and to direct them where they will have the greatest impact.
Build your organisation's model in 48 hours
For a 1,000-person organisation, the estimated annual cost of workforce capacity loss - absence, presenteeism and turnover combined - is £6.6 million. Parachute will build the financial model for your organisation in 48 hours, at no cost and with no commitment required.
Start the conversation by emailing [email protected]
Sources
Office for National Statistics. Sickness Absence in the UK Labour Market: 2023 and 2024. June 2025.
CIPD. Health and Wellbeing at Work Survey. 2024.
WTW. Absence Management Survey 2023: Absence Trends in the United Kingdom. February 2024
O'Halloran J and Thomas C. Healthy Industry, Prosperous Economy. IPPR, July 2024
Deloitte UK. Mental Health and Employers: The Case for Investment (4th edition). May 2024.